bf/NASDAQ:LSTA_icon.jpeg

NASDAQ:LSTA

Lisata Therapeutics, Inc.

  • Stock

USD

Last Close

3.01

30/08 20:00

Market Cap

28.33M

Beta: 1.22

Volume Today

4.58K

Avg: 8.86K

PE Ratio

−1.29

PFCF: −1.02

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
14.67M
-
17.94M
22.29%
22.49M
25.36%
35.28M
56.90%
121.37M
-
cost of revenue
12.95M
-
15.68M
21.10%
20.16M
28.58%
31.14M
54.45%
65K
-
63K
3.08%
55K
12.70%
57.60M
104,629.09%
189K
99.67%
gross profit
1.72M
-
2.26M
31.32%
2.33M
3.02%
4.15M
78.12%
-65K
-
-63K
3.08%
-55K
12.70%
63.77M
116,047.27%
-189K
100.30%
selling and marketing expenses
general and administrative expenses
11.75M
-
9.39M
20.06%
9.29M
1.04%
9.89M
6.42%
11.37M
14.94%
14.14M
24.37%
selling general and administrative expenses
21.61M
-
30.81M
42.54%
30.01M
2.60%
20.37M
32.10%
11.75M
42.33%
9.39M
20.06%
9.29M
1.04%
9.89M
6.42%
11.37M
14.94%
14.14M
24.37%
12.79M
9.59%
research and development expenses
16.92M
-
29.19M
72.57%
23.90M
18.14%
15.11M
36.78%
15.84M
4.86%
7.59M
52.07%
10.80M
42.18%
9.25M
14.30%
17.68M
91.07%
43.46M
145.81%
12.73M
70.70%
other expenses
-1.61M
-
2.93M
281.19%
17.72M
505.73%
21.96K
99.88%
273.10K
1,143.80%
824K
201.72%
740K
10.19%
132K
82.16%
-75K
156.82%
-155K
106.67%
cost and expenses
51.48M
-
75.68M
47.02%
74.06M
2.14%
66.62M
10.05%
27.59M
58.58%
16.99M
38.44%
20.09M
18.28%
19.14M
4.71%
29.05M
51.74%
57.60M
98.28%
25.71M
55.37%
operating expenses
38.53M
-
60.00M
55.72%
53.90M
10.16%
35.48M
34.17%
27.59M
22.24%
16.99M
38.44%
20.09M
18.28%
19.14M
4.71%
29.05M
51.74%
57.60M
98.28%
25.52M
55.70%
interest expense
281.42K
-
755.70K
168.53%
2.13M
181.65%
1.86M
12.72%
377.77K
79.66%
5K
98.68%
-1.95M
-
ebitda
-36.82M
-
-52.63M
42.94%
-31.17M
40.78%
-28.57M
8.33%
-26.95M
5.68%
-15.94M
40.86%
-19.29M
21.01%
-19.08M
1.06%
-29.15M
52.74%
-58.58M
101.00%
-25.52M
56.44%
operating income
-36.81M
-
-57.74M
56.87%
-113.85M
97.17%
-31.34M
72.48%
-27.59M
11.94%
-16.99M
38.44%
-20.09M
18.28%
-19.14M
4.71%
-29.05M
51.74%
-57.60M
98.28%
-25.71M
55.37%
depreciation and amortization
1.61M
-
2.19M
36.21%
2.69M
22.86%
2.74M
2.12%
372.00K
86.44%
225K
39.52%
805K
257.78%
63K
92.17%
-96K
252.38%
-983K
923.96%
189K
119.23%
total other income expenses net
-1.61M
-
2.93M
281.19%
-44.55M
1,622.55%
21.96K
100.05%
273.10K
1,143.80%
824K
201.72%
740K
10.19%
132K
82.16%
76K
42.42%
897K
1,080.26%
2.54M
182.94%
income before tax
-38.71M
-
-55.57M
43.57%
-98.25M
76.81%
-33.17M
66.24%
-27.70M
16.50%
-16.17M
41.63%
-19.35M
19.69%
-19.01M
1.75%
-28.97M
52.39%
-56.70M
95.71%
-23.17M
59.14%
income tax expense
780.10K
-
-104.20K
113.36%
-17.24M
16,448.17%
138.04K
100.80%
-11.53M
8,450.28%
-1K
99.99%
749K
75,000%
-10.87M
1,551.54%
-1.51M
86.13%
-2.48M
64.39%
-2.33M
6.01%
net income
-38.98M
-
-54.87M
40.77%
-80.89M
47.41%
-32.66M
59.63%
22.98M
170.37%
-16.17M
170.36%
-20.10M
24.33%
-8.14M
59.50%
-27.47M
237.38%
-54.23M
97.43%
-20.84M
61.57%
weighted average shs out
136.64K
-
218.37K
59.82%
323.39K
48.09%
436.55K
34.99%
597.93K
36.97%
645.93K
8.03%
688.33K
6.56%
1.03M
49.54%
3.69M
258.24%
5.18M
40.47%
8.07M
55.85%
weighted average shs out dil
136.64K
-
218.37K
59.82%
323.39K
48.09%
436.55K
34.99%
597.93K
36.97%
645.93K
8.03%
688.33K
6.56%
1.03M
49.54%
3.69M
258.24%
5.18M
40.47%
8.07M
55.85%
eps
-285.29
-
-251.28
11.92%
-250.12
0.46%
-74.81
70.09%
38.40
151.33%
-25.03
165.18%
-29.20
16.66%
-7.91
72.91%
-7.45
5.82%
-10.47
40.54%
-2.58
75.36%
epsdiluted
-285.29
-
-251.28
11.92%
-250.12
0.46%
-74.81
70.09%
38.40
151.33%
-25.03
165.18%
-29.20
16.66%
-7.91
72.91%
-7.45
5.82%
-10.47
40.54%
-2.58
75.36%

All numbers in USD (except ratios and percentages)